Cell therapy consists of the prevention or treatment of human diseases by the administration of viable cells which have been selected, cultured, often multiplied, and possibly pharmacologically treated or altered outside the body (ex-vivo). This article will present the wide array of different approaches present today in Europe for the regulation of cell therapy products and envision how cell therapy products could be regulated in the near future.
Emmanuelle Voisin
2003 – DIA
Cell Therapy – Current Regulatory Framework, Forum article for April 2003
Download the full publication now
Fill in the form to download the content
publication by
Emmanuelle M. Voisin, PhD
Founder and CEO
Dr. Emmanuelle Voisin founded Voisin Consulting Life Sciences (VCLS) in 1997. The firm has become a leading advisor to Biotech,…
View profile
All our resources 
